Ursprung des Netzwerks ersten Grades von David Yeomans
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Trigemina, Inc.
 Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Yeomans
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Chairman | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Founder General Counsel | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Director/Board Member | |
| COPENHAGEN CAPITAL A/S | Real Estate Development | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| STADA ARZNEIMITTEL | Pharmaceuticals: Major | Director/Board Member | |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
| BIOTEST AG | Pharmaceuticals: Other | Chairman | |
Amarin Pharmaceuticals, Inc.
 Amarin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Amarin Pharmaceuticals, Inc. is a pharmaceutical company that manufactures and develops pharmaceuticals. The company is based in Mill Valley, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Indiana University | College/University | Undergraduate Degree Masters Business Admin | |
| The University of Chicago | College/University | Graduate Degree Masters Business Admin | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Graduate Degree | |
| Universität zu Köln | College/University | Graduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
TBG Insurance Services Corp.
 TBG Insurance Services Corp. Insurance Brokers/ServicesFinance TBG Insurance Services Corp. engages in the provision of insurance and financial services. It specializes in products and services related to executive compensation and retirement programs. The company was founded in 1982 and is headquartered in Los Angeles, CA. | Insurance Brokers/Services | Chairman | |
MullinTBG
 MullinTBG Investment Banks/BrokersFinance Founded in 2006 as the result of a merge between Mullin Consulting and TBG Financial, MullinTBG is a broker/dealer headquartered in El Segundo, California. The firm is a provider of nonqualified executive benefits to which Fortune 1000 and emerging growth companies can outsource all aspects of their executive benefit, compensation and retirement income planning needs. They are a member of the NASD and the SIPC. They are a subsidiary of the Prudential Insurance Co. of America and their ultimate parent is Prudential Financial, Inc. (NYSE: PRU). | Investment Banks/Brokers | Founder | |
| St. Joseph's College | College/University | Undergraduate Degree | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BPC Plasma, Inc.
 BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | Chairman | |
Lilly Deutschland GmbH
 Lilly Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Deutschland GmbH is a pharmaceutical company based in Bad Homburg, Germany. The German company manufactures pharmaceutical products. The company was founded in 1960 by Eli Lilly. The CEO is Kadir Tepebasi. | Pharmaceuticals: Major | Sales & Marketing | |
| Amgen (Europe) GmbH | Corporate Officer/Principal | ||
| CLEARPOINT NEURO, INC. | Medical Specialties | Director/Board Member | |
| Deutsche Sporthochschule Köln | College/University | Graduate Degree | |
| University of San Francisco School of Law | College/University | Graduate Degree | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member | |
| SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Chairman | |
Ferring Holding, Inc.
 Ferring Holding, Inc. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Holding, Inc. is a company that manufactures and sells pharmaceuticals. The company is based in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
NavBio AG
 NavBio AG Miscellaneous Commercial ServicesCommercial Services NavBio AG provides business and management consulting services. | Miscellaneous Commercial Services | Director/Board Member | |
Trizell Ltd.
 Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Biotechnology | Director/Board Member | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Idt Biologika Corp. | Director/Board Member | ||
| AN2 THERAPEUTICS, INC. | Biotechnology | Founder | |
Semdor Pharma Group GmbH
 Semdor Pharma Group GmbH Pharmaceuticals: MajorHealth Technology Semdor Pharma Group GmbH is a German pharmaceutical company that specializes in narcotics and medical cannabis. With the merger of Cannamedical Pharma and PS Pharma, it is the only full-service pharmaceutical narcotics company in Germany that has its own medical cannabis brand and sales team. Semdor Pharma Group is the leading pharmaceutical company for narcotics and medical cannabis in Germany. | Pharmaceuticals: Major | Director/Board Member | |
| Trizell Holding SA | Director/Board Member | ||
| Dessau-Rosslau | Real Estate Development | Director/Board Member | |
IDT Biologika GmbH
 IDT Biologika GmbH Pharmaceuticals: MajorHealth Technology IDT Biologika GmbH manufactures and distributes vaccines and biopharmaceuticals for the protection of human and animal health. The firm offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for viral and bacterial human and animal health vaccines. The company was founded on July 1, 1921 and is headquartered in Dessau-Rosslau, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| World Anti-Doping Agency | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 32 |
| Deutschland | 9 |
| Schweiz | 4 |
| Vereinigtes Königreich | 4 |
| Dänemark | 3 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 5 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 109 |
| Chairman | 24 |
| Corporate Officer/Principal | 23 |
| Independent Dir/Board Member | 20 |
| Chief Executive Officer | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Joseph Zakrzewski | 30 |
| Rolf K. Hoffmann | 27 |
| Scott Braunstein | 26 |
| Lowell E. Sears | 22 |
| Will Price | 21 |
| Mark R. Benham | 17 |
| Stanley Abel | 13 |
| Alexander Seelenberger Farba | 13 |
| Rick Orr | 11 |
| Shashidhar H. Kori | 9 |
| Mike R. Shute | 4 |
| George Miljanich | 4 |
| Justin Du Bois | 3 |
| Bruce C. Conway | 3 |
| John Mulcahy | 3 |
- Börse
- Insiders
- David Yeomans
- Unternehmensverbindungen